Skip to main content

Stress, Psychological

0
Pipeline Programs
8
Companies
10
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 11 programs with unclassified modality

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
4 programs
Cognitive Stress TestingN/A1 trial
FOCUS-ECN/A1 trial
Families OverComing Under StressN/A
Stress; Trier Social Stress TaskN/A1 trial
Active Trials
NCT05026333Completed100Est. Jul 2022
NCT04598100Completed199Est. Jun 2018
NCT03828604Completed57Est. May 2018
Human BioSciences
Human BioSciencesWV - Martinsburg
3 programs
CHIMEN/A1 trial
CPIPE TrainingN/A1 trial
Families OverComing Under StressN/A1 trial
Active Trials
NCT04815252Completed120Est. May 2023
NCT06085105Enrolling By Invitation6,400Est. Jan 2029
NCT05264415Completed65Est. Nov 2024
Martin Pharmaceuticals
1 program
Multidimensional stress prevention programN/A1 trial
Active Trials
NCT03861013Completed64Est. Jun 2017
Corner Therapeutics
Corner TherapeuticsMA - Watertown
1 program
Relaxation ApplicationN/A1 trial
Active Trials
NCT04292145Recruiting100Est. Dec 2024
Verona Pharma
Verona PharmaUK - London
1 program
Self Help PlusN/A
Crescent Biopharma
1 program
Self Help PlusN/A1 trial
Active Trials
NCT03571347Completed459Est. Dec 2020
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
MinocyclinePHASE_4Small Molecule1 trial
Active Trials
NCT06044090Completed10Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Johnson & JohnsonMinocycline
Human BioSciencesCPIPE Training
Human BioSciencesFamilies OverComing Under Stress
Angeles TherapeuticsCognitive Stress Testing
Human BioSciencesCHIME
Corner TherapeuticsRelaxation Application
Crescent BiopharmaSelf Help Plus
Angeles TherapeuticsStress; Trier Social Stress Task
Martin PharmaceuticalsMultidimensional stress prevention program
Angeles TherapeuticsFOCUS-EC

Clinical Trials (10)

Total enrollment: 7,574 patients across 10 trials

NCT06044090Johnson & JohnsonMinocycline

Brain and Stress Study

Start: Sep 2022Est. completion: Dec 202310 patients
Phase 4Completed
NCT06085105Human BioSciencesCPIPE Training

Caring for Providers to Improve Patient Experience (CPIPE) Trial

Start: Mar 2024Est. completion: Jan 20296,400 patients
N/AEnrolling By Invitation
NCT05264415Human BioSciencesFamilies OverComing Under Stress

Intergenerational Transmission of Traumatic Stress

Start: Oct 2021Est. completion: Nov 202465 patients
N/ACompleted
NCT05026333Angeles TherapeuticsCognitive Stress Testing

Cognitive and Biological Responses in Stress

Start: Jun 2021Est. completion: Jul 2022100 patients
N/ACompleted
NCT04815252Human BioSciencesCHIME

Mindfulness Intervention for Early Childhood Educators

Start: Sep 2020Est. completion: May 2023120 patients
N/ACompleted
NCT04292145Corner TherapeuticsRelaxation Application

Effectiveness of Relaxation Techniques

Start: Apr 2020Est. completion: Dec 2024100 patients
N/ARecruiting
NCT03571347Crescent BiopharmaSelf Help Plus

Self Help Plus for Asylum Seekers and Refugees in Europe

Start: Sep 2018Est. completion: Dec 2020459 patients
N/ACompleted
NCT03828604Angeles TherapeuticsStress; Trier Social Stress Task

Stress-Induced Inflammation and Reward Processing

Start: May 2017Est. completion: May 201857 patients
N/ACompleted
NCT03861013Martin PharmaceuticalsMultidimensional stress prevention program

Reward Under Stress: Effects of a Multidimensional Stress Prevention Program in University Students

Start: Mar 2015Est. completion: Jun 201764 patients
N/ACompleted
NCT04598100Angeles TherapeuticsFOCUS-EC

Promoting Resiliency in Veteran Families With Young Children

Start: Apr 2014Est. completion: Jun 2018199 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 7,574 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.